CI vs RYTM
Cigna Corp (CI) versus Rhythm Pharmaceuticals Inc (RYTM) — a side-by-side from cached financials, not a winner call.
Cigna Corp (CI) is a healthcare plans company listed on US.
Rhythm Pharmaceuticals Inc (RYTM) is a biotechnology company listed on NASDAQ.
Latest reported CI revenue for 2025-12-31 was $274.90B. Net income was $5.96B. Revenue was up 11.2% from 2024-12-31 to 2025-12-31. CI currently screens at market cap $71.62B and trailing P/E 2.4.
Latest reported RYTM revenue for 2024-12-31 was $130.1M. Net income was -$260.6M. Revenue was up 68.1% from 2023-12-31 to 2024-12-31. RYTM currently screens at market cap $6.49B.
CI currently screens at market cap $71.62B and trailing P/E 2.4. RYTM currently screens at market cap $6.49B.
Not investment advice. Open the CI and RYTM stock pages for the full models.
Not investment advice.